AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,708,250 | +34.3% | 716,139 | +38.7% | 2.32% | +78.2% |
| Q2 2023 | $6,482,706 | +50.5% | 516,139 | +32.9% | 1.30% | +16.6% |
| Q1 2023 | $4,306,158 | -11.9% | 388,292 | -3.0% | 1.12% | -11.8% |
| Q4 2022 | $4,889,006 | +19.2% | 400,410 | +1.9% | 1.27% | +30.5% |
| Q3 2022 | $4,102,000 | -22.9% | 392,946 | -20.7% | 0.97% | -34.3% |
| Q2 2022 | $5,323,000 | +13.4% | 495,603 | 0.0% | 1.48% | +17.5% |
| Q1 2022 | $4,693,000 | -20.8% | 495,603 | -3.5% | 1.26% | +16.5% |
| Q4 2021 | $5,929,000 | +13.6% | 513,333 | -6.1% | 1.08% | +33.5% |
| Q3 2021 | $5,220,000 | – | 546,558 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |